Sandra Cohen, MD¹, Nadia M. Bambace, MD², Lea Bernard, MD¹, Imran Ahmad, MD¹, Jean Roy, MD³, Sylvie Lachance, MD¹, Jean-Sebastien Delisle, MD, PhD⁴, Thomas L. Kiss, MD¹, Denis-Claude Roy, MD⁴, Olivier Veilleux, MD⁵ and Guy Sauvageau, MD/PhD⁶

¹Hematology-Oncology and Cell Therapy University Institute, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
²Baptist Health South Florida, Miami Cancer Institute, Miami, FL
³Institut universitaire d’hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada
⁴Hematology-Oncology and Cell Therapy University Institute, Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada
⁵Hopital Maisonneuve Rosemont, Université de Montréal, Institut Universitaire d'Hématologie Oncologie et Thérapie Cellulaire, Montreal, QC, Canada
⁶Institut de recherche en Immunologie et Cancer, Université de Montréal, Montreal, QC, Canada

Anne Herrmann, PhD^1,2,3*, Helene Schoemans, MD^4*, Eva Wilhelm^2*, Guy Tavori^5*, Nada Hamad, MBBS, MSc, BSc⁶, Meredith A. Cowden^7*, Anna Barata^8*, Francis A. Ayuk, M.D.^9*, Wolfgang Herr, MD², Joerg Halter, MD^10*, Stephanie Lee, MD, MPH¹¹ and Daniel Wolff, MD^2*

¹Department of Epidemiology and Preventive Medicine, Division of Medical Sociology, University of Regensburg, Regensburg, Germany
²Internal Medicine III - Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
³Bavarian Center for Cancer Research, Regensburg, Germany
⁴Department of Hematology, University Hospitals Leuven, KU Leuven - University of Leuven, Leuven, Belgium
⁵Department of Hematology, Tel Aviv Medical Center, Tel Aviv, Israel
⁶St Vincent's Hospital, Sydney, NSW, Australia
⁷Meredith A. Cowden Foundation, Cleveland, OH
⁸Massachusetts General Hospital, Boston, MA
⁹Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹⁰Dept. of Hematology, University Hospital Basel, Basel, Switzerland
¹¹Fred Hutchinson Cancer Center, Seattle, WA

Khalil Hassan, MD^*, Anmol Baranwal, MBBS^*, Abhishek A. Mangaonkar, MBBS, Mehrdad Hefazi, MD, Aasyia Matin, MBBS^*, Mark R. Litzow, MD, William J. Hogan, MD, Mithun V Shah, M.D., Ph.D. and Hassan B Alkhateeb, MD^*

Division of Hematology, Mayo Clinic, Rochester, MN

Lorenzo Iovino, MD, PhD^1,2, Ningxin Ma, PhD^2*, Chris Davis^2*, Linda M Glockling^2*, Sophie L Martin^2*, Filippo Milano, MD^1,3, Jordan Gauthier, MD, MSc^1,2, Naveed Ali, MD, MBBS^1,2, Ted Gooley, PhD^1,2*, Qian Vicky Wu, PhD^2* and Mohamed Sorror, MD, MSc^1,2

¹University of Washington, Seattle, WA
²Fred Hutchinson Cancer Center, Seattle, WA
³Fred Hutchinson Cancer Research Center, Seattle, WA

Tatsuro Hirao^1*, Hisashi Yamamoto, MD, PhD^1*, Mika Kuno, MD^1*, Otoya Watanabe, MD^1*, Kyosuke Yamaguchi, MD^2*, Kosei Kageyama, MD^2*, Daisuke Kaji, MD, PhD^1*, Yuki Taya, MD, PhD^1*, Aya Nishida, MD^1*, Kazuya Ishiwata, MD^2*, Shinsuke Takagi, MD, PhD^1*, Go Yamamoto, MD, PhD^1*, Atsushi Wake, MD, PhD² and Naoyuki Uchida¹

¹Department of Hematology, Toranomon Hospital, Tokyo, Japan
²Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan

Neel S. Bhatt, MBBS, MPH^1,2, Elizabeth M Hellewell, BS^3*, Kevin Ng, M.S.^3*, Ted Gooley, PhD^4*, Anthony D. Sung, MD⁵, Allison O. Taylor, MD, MS^6*, Sanghee Hong, MD⁷, Nausheen Ahmed, MD⁸, Cherie Morey, MD^9*, Sarah Fitzmaurice^9*, Vanessa E. Kennedy, MD¹⁰, Michelle Lauer^11*, Andrew D. Trunk, MD¹², Betty K. Hamilton, MD¹³, Akshay Sharma, MBBS¹⁴, Zoey Phelps-Bergeron^15*, LaQuisa Hill, MD^16*, Rawan Faramand, MD¹⁷, Hien Liu, MD¹⁸, Lena E Winestone, MD¹⁹, Geoffrey Cheng¹⁹, Manuel Espinoza-Gutarra, MD²⁰, Omer Jamy, MD²⁰, Maria Odstrcil Bobillo, MD^21*, Brian McClune, DO²¹, Mariam T. Nawas, MD²², Samuel J. Yates, MD, MSc²³, Miki Nishitani, MD, BS²⁴, Takuto Takahashi, MD, PhD^24*, Jane Koo, MD^25*, Kasiani C Myers, MD²⁶, Kris Michael Mahadeo, MD²⁷, Andrea Bauchat, DO^28*, Laurie K Pearson, MD²⁹, Ritika Walia, MD^30*, Kelsea Seago, PharmD, RPh^31*, Spencer Yingling, PharmD^32*, Cory Edgar, PA-C^33*, Amy Browning, APRN^33* and Catherine J. Lee, MD, MSc²

¹Department of Pediatrics, Division of Hematology/Oncology, University of Washington School of Medicine, Seattle, WA
²Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
³Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁴University of Washington, Seattle, WA
⁵Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC
⁶Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC
⁷Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
⁸Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
⁹Division of hematologic malignancies and cellular therapeutics, University of Kansas Cancer Center, Westwood, KS
¹⁰Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
¹¹Stanford University, Stanford, CA
¹²Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Shaker Heights, OH
¹³Cleveland Clinic Foundation, Cleveland, OH
¹⁴Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
¹⁵Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN
¹⁶Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Methodist Hospital, Houston, TX
¹⁷Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
¹⁸Department of Blood and Marrow Transplant and Cellular Immunotherapy, , H. Lee Moffitt Cancer Center, Tampa, FL
¹⁹Division of Allergy, Immunology, & BMT, Department of Pediatrics, UCSF Benioff Children's Hospitals, San Francisco, CA
²⁰O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL
²¹Huntsman Cancer Institute, University of Utah, Division of Hematology and Hematologic Malignancies, Salt Lake City, UT
²²Department of Medicine, Section of Hematology/Oncology, University of Chicago, Oak Park, IL
²³Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
²⁴Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
²⁵Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
²⁶Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
²⁷Pediatric Transplant and Cellular Therapy, Duke University, Durham, NC
²⁸Pediatric Transplantation and Cellular Therapy, Duke University, Durham, NC
²⁹UMass Memorial Medical Center, Department of Medicine, Waltham, MA
³⁰UMass Memorial Medical Center, Department of Medicine, Worcester, MA
³¹West Virginia University Medicine, Morgantown, WV
³²West Virginia University Medicine, Morgantown
³³AdventHealth, Orlando, FL

Zhihui Li^1*, Keyan Yang^2*, Lei Wang^1*, Xianxuan Wang^1*, Xiaopei Wen^1*, Jingjing Wang^1*, Jing Li^1*, Yanzhi Song^1*, Yongqiang Zhao^1*, Qinlong Zheng, MD^3* and Tong Wu, MD¹

¹Department of Bone Marrow Transplantation, Beijing GoBroad Boren Hospital, Beijing, China
²Laboratory of Molecular Diagnostics, Beijing Boren Hospital, Beijing, China
³Laboratory of Molecular Diagnostics, Beijing GoBroad Boren Hospital, Beijing, China

Yifei Huang^1*, Ren Lin, PhD^2*, Shanyu Zhang^1*, Zhiping Fan^1*, Fen Huang^1*, Li Xuan^3*, Na Xu^1*, Hui Liu^1*, Zhixiang Wang^1*, Min Dai, MD^4*, Hua Jin^5*, Jing Sun^1* and Qifa Liu, MD¹

¹Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
²Nanfang Hospital, Guangzhou, China
³Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, China
⁴Nanfang Hospital Southern Medical University, Guangzhou, China
⁵Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China

Osariemen Ogiamien^1*, Sitong Chen, MPH^2*, MHD Monzr M. Al Malki, MD³, Andrew Artz, MD, MS², Liezl Atencio^2*, Alysia Bosworth, BA^2*, Meagan Echevarria^4*, Caitlyn Estrada^2*, Mareen Kassabian^2*, Lanie Lindenfeld^2*, Ryotaro Nakamura, MD⁵, June-Wha Rhee^2*, F. Lennie Wong, PhD⁴, Saro Armenian, DO, MPH² and Rusha Bhandari, MD, MS⁴

¹University of California Riverside Science Library, Riverside, CA
²City of Hope National Medical Center, Duarte, CA
³Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁴City of Hope, Duarte, CA
⁵Hematology and HCT, City of Hope National Medical Center, Duarte, CA

Hiroaki Shimizu, MD, PhD¹, Masahiro Ashizawa^2*, Yoshihiro Inamoto, MD, PhD³, Jun Kato, MD, PhD^4*, Shun-Ichi Kimura, MD^5*, Masatsugu Tanaka, MD^6*, Shokichi Tsukamoto, MD, PhD⁷, Ayaka Nishihara^7*, Masako Toyosaki, MD^8*, Yuki Nakajima, MD^9*, Satoru Takada, MD¹⁰, Nobuyuki Aotsuka, MD, PhD^11*, Tomomi Takei, MD^12*, Maki Hagihara, MD, PhD^9*, Katsuhiro Shono, MD, PhD^13*, Yoshihiro Hatta, MD¹⁴, Yoshihiro Umezawa, MD, PhD^15*, Nobuhiko Kobayashi, MD^16*, Ken Naganuma^17*, Chikako Ohwada, MD, PhD¹⁸ and Yoshinobu Kanda, MD, PhD^19*

¹Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Japan
²Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke city, Japan
³Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
⁴Division of Hematology, Keio university school of medicine, Shinjuku-Ku, JPN
⁵Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
⁶Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
⁷Department of Hematology, Chiba University Hospital, Chiba, Japan
⁸Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan
⁹Yokohama City University Medical Center, Yokohama, JPN
¹⁰Saiseikai Maebashi Hospital, Maebashi, JPN
¹¹Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan
¹²Japanese Red Cross Medical Center, Tokyo, Japan
¹³Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
¹⁴Department of Medicine Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan
¹⁵Tokyo Medical and Dental University, Bunkyo-Ku, TKY, JPN
¹⁶Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
¹⁷Saitama Medical Center, Saitama Medical University, Kawagoe, JPN
¹⁸Department of Hematology, International University of Health and Welfare School of Medicine, Narita, Japan
¹⁹Division of Hematology, Jichi Medical University, Tochigi, Japan

Shotaro Shimada^1*, Naoyuki Uchida², Hisashi Yamamoto, MD, PhD^2*, Otoya Watanabe, MD^2*, Daisuke Kaji, MD, PhD^2*, Yuki Taya, MD, PhD^3*, Aya Nishida, MD^2*, Shinsuke Takagi, MD, PhD^2*, Yuki Asano-Mori, MD⁴ and Go Yamamoto, MD, PhD^2*

¹Department of hematology, Toranomon hospital, Tokyo, Japan
²Department of Hematology, Toranomon Hospital, Tokyo, Japan
³Department of Hematology, Toranomon Hospital, Minato-Ku, Japan
⁴Department of Transfusion and Cell Therapy, Toranomon Hospital, Tokyo, Japan

Garima Nirmal, MD, DM^1*, Gurpreet Singh, MD^1*, Vaibhav Chadha, MD^1*, Nikhil Gupta, MD^1*, Nidhi Srivastava, MD^1*, Velu Nair, MBBS, MD², Himshikha Yadav^1*, Sanjay Sharma^1* and Gaurav Kharya, DCH, DNB, FIAP^1*

¹Indraprastha Apollo Hospital, Delhi, India
²Apollo Hospitals Ahmedabad, Detrojrampura, Gujarat, India

Gauri Wechalekar^1,2*, Alia Cibich, BHSc (Hons)^1,2*, Monika Kutyna, PhD^1,2,3*, Naranie Shanmuganathan, MBBS, PhD, FRACP, FRCPA^2,4, Usha Chandra Sekaran, MBBS, FRACP, FRCPA^5*, Deepak Singhal, MBBS, MD, FRACP, FRCPA^2,4*, Ashanka Mahilal Beligaswatte, BA, MBBS, MD, FRACP, FRCPA², Leanne Purins^6*, Christopher N. Hahn, PhD^6,7*, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA^2,3, Peter Bardy, MBBS^2*, Duncan Purtill, MBBS, FRACP, FRCPA^5*, Ashish Bajel, MBBS, FRACP, FRCPA⁸, Susan Branford, PhD^6,7 and Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA^2,3

¹Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia
²Department of Haematology, Central Adelaide Local Health Network, Adelaide, SA, Australia
³South Australian Health and Medical Research Institute, Adelaide, SA, Australia
⁴South Australian Health and Medical Research Institute, Adelaide, Australia
⁵Haematology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia
⁶SA Pathology, Adelaide, SA, Australia
⁷University of South Australia, Adelaide, SA, Australia
⁸Clinical Haematology, Royal Melbourne Hospital, Parkville, Australia

Yana Stepanishyna, PhD^1,2*, Sebastian Wittnebel^3*, Fabio Andreozzi^3*, Adriano Salaroli^3*, Paulus Kristanto^4*, Chloe Spilleboudt^3*, Marie France Jaivenois^3*, Sandra Michiels^3*, Rezarta Ajazi^3*, Charlotte Vandevoorde^3*, Virginie De Wilde^3*, Nathalie Meuleman³, Philippe Lewalle^3*, Dominique Bron^3* and Sule Mine Bakanay Ozturk^3,5*

¹Jules Bordet Institute (HUB/ULB), Kyiv, Ukraine
²EHA Research fellow (Ukraine Bridge funding program), Brussels, Belgium
³Jules Bordet Institute (HUB/ULB), Brussels, Belgium
⁴Information Management Unit, Jules Bordet Institute, (HUB/ULB), Brussels, Belgium
⁵Ankara Yıldırım B. University, Bilkent City Hospital, Ankara, Turkey

Eshrak Al-Shaibani^1*, Yu Cai^2*, Xianmin Song, MD^2*, Mohsen Al Zahrani^3*, Mohamed Elemary, MD, MSc, PhD^4*, Muhned Alhumaid^5*, Hanan Alkhaldi, MD^6*, Ayman Saad, MD⁶, Francesca Biavasco^7*, Robert Zeiser, MD⁷, Joon Ho Moon, MD, PhD^8*, Sang Kyun Sohn, MD, PhD^8*, Jonas Mattsson, MD, PhD^1* and Dennis Dong Hwan Kim, MD, PhD¹

¹Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada
²Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
³King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
⁴Provincial Hematology and Blood and Marrow Transplant Program, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK, Canada
⁵Department of Hematology, King Fahad Medical City, Riyadh, Saudi Arabia
⁶Dept of Hematology, Stem Cell Transplantation and Cellular Therapy , KFSHRC, Riyadh, Saudi Arabia
⁷University of Freiburg Medical Centre, Department of Medicine I, Freiburg, Germany
⁸Kyungpook National University Hospital, Daegu, Korea, Republic of (South)

Kanishka Uttam Chandani¹, Siddharth pravin Agrawal, MD^2*, Maharshi Raval^3*, Dev Lotia^4*, Niti Chokshi^4* and Ahmed Nadeem, MD⁵

¹New York Medical College, Landmark Medical Center, Cumberland, RI
²New York Medical College, Landmark medical center, Woonsocket, RI
³St. Elizabeth's Medical center, Boston, MA
⁴Smt. NHL Municipal Medical College, Ahmedabad, India
⁵New York Medical College, Landmark Cancer Center, Woonsocket

Moazzam Shahzad, MD^1,2,3, Aqsa Mumtaz, MD, MBBS^2,3*, Ahmad Basharat^2,3*, Sohaib Irfan, MD^2,3*, Muhammad Hamza Sadiq, MBBS^2,3*, Faryal Altaf, MD^2,3*, Sarah Faisal^2,3*, Numan Akram^2,3*, Muhammad Zeeshan^2,3*, Muhammad Kashif Amin, MD^2,3,4*, Sibgha Gull Chaudhary, MD^2,3,4*, Iqra Anwar, MBBS^2,3,4*, Matthew McGuirk^2,3,4*, Anurag Singh, MD^2,3* and Muhammad Umair Mushtaq, MD^2,3,4

¹H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁴US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS

Otoya Watanabe, MD^1*, Hisashi Yamamoto, MD, PhD^1*, Kyosuke Yamaguchi, MD^2*, Kosei Kageyama, MD^2*, Daisuke Kaji, MD, PhD^1*, Yuki Taya, MD, PhD^3*, Aya Nishida, MD^1*, Kazuya Ishiwata, MD^2*, Shinsuke Takagi, MD, PhD^1*, Go Yamamoto, MD, PhD^1*, Atsushi Wake, MD, PhD² and Naoyuki Uchida¹

¹Department of Hematology, Toranomon Hospital, Tokyo, Japan
²Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan
³Department of Hematology, Toranomon Hospital, Minato-Ku, Japan

Xingyu Cao^1,2*, Yue Lu^1,2*, Jian-Ping Zhang^1,2*, Deyan Liu^1,2*, Zhijie Wei^1,2*, Yanli Zhao^1,2*, Jiarui Zhou^1,2*, Min Xiong^1,2*, Ruijuan Sun^2,3*, Jing Long, MD^2* and Peihua Lu, MD^1,2,4

¹Hebei Yanda Lu Daopei Hospital, Langfang, China
²Beijing Lu Daopei Hospital, Beijing, China
³Hebei Yanda Lu Daopei Hospital, Beijing, China
⁴Beijing Lu Daopei Institute of Hematology, Beijing, China

Diana T Samuels, PharmD^1*, Brian J. Ball, MD², NI-Chun Tsai, MS^3*, Amanda Blackmon, DO, MS^4*, Vaibhav Agrawal, M.D.², Hoda Pourhassan, MD², Idoroenyi Amanam, MD⁵, Paul B. Koller, MD², Shukaib Arslan, MD^5*, Salman Otoukesh, MD⁵, Karamjeet S Sandhu, MD², Ibrahim Aldoss, MD², Haris Ali, MD⁵, Amandeep Salhotra, MD⁵, MHD Monzr M. Al Malki, MD², Andrew Artz, MD, MS⁶, Pamela S. Becker, MD, PhD⁷, Ahmed Aribi, MD^8*, Eileen Patricia Smith, MD⁹, Stephen J. Forman, MD, FACP¹⁰, Anthony S. Stein, MD², Guido Marcucci¹¹, Ryotaro Nakamura, MD² and Vinod Pullarkat, MD¹²

¹Department of Pharmacy, City of Hope National Medical Center, Duarte, CA
²Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
⁴Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁵Hematology and HCT, City of Hope National Medical Center, Duarte, CA
⁶City of Hope National Medical Center, Duarte, CA
⁷Hematology/HCT, City of Hope, Duarte, CA
⁸Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
⁹Hematology/HCT, City of Hope National Medical Center, Duarte, CA
¹⁰Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
¹¹Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope Medical Center and Beckman Research Institute, Duarte, CA
¹²Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Moazzam Shahzad, MD^1,2, Zouina Sarfraz, MBBS^1,3*, Ben Ponvilawan, MD^1,3*, Muhammad Kashif Amin, MD^3*, Matthew McGuirk^1,3,4*, Sibgha Gull Chaudhary, MD^1,3,4*, Robin Park^5*, Iqra Anwar, MBBS^1,3*, Raheel Iftikhar, MBBS, FCPS^1,3, Nausheen Ahmed, MD^1,3,4*, Mehdi Hamadani, MD⁶, Joseph P. McGuirk, DO^1,3,4 and Muhammad Umair Mushtaq^1,3,4

¹Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
²Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁴US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
⁵H Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
⁶Department of Medicine, Medical College of Wisconsin, Milwaukee, WI